ISPOR
ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
ISPOR Membership: Becoming an ISPOR member offers unique advantages in health economics and outcomes research (HEOR). Members gain valuable benefits, global networking opportunities, and platforms for advancing HEOR excellence, joining nearly 18,000 professionals across 100+ countries who are dedicated to improving healthcare decision making worldwide. https://www.ispor.org/membership
HEOR Learning Lab™ is ISPOR’s on-demand educational resource, offering unlimited video content from conferences and events. Covering key topics like real-world evidence, digital health, AI, and health policy, it supports continuous learning for HEOR professionals and interested learners worldwide. https://www.ispor.org/welcome-HEOR-Learning-Lab
FEATURED PRODUCTS AND SERVICES
-
![clinical-regulation-GettyImages-1423366794]( "US Healthcare System Overview")
A clear guide to U.S. coverage, regulation, and reimbursement: who decides care, how products gain access, and how policy and financing shape cost, value, and patient access.
-
![top-10-trends-GettyImages-2231462868]( "Top 10 HEOR Trends Report")
Emerging trends in HEOR reveal how AI, real‑world evidence, value‑based care, digital health, and evolving affordability pressures are reshaping global healthcare.
-
![Artificial intelligence machine learning, cyber security and digital data, Robotic system, technology-GettyImages-1983353272]( "Real-World Data And Real-World Evidence")
As clinical research evolves, RWD and RWE play a crucial role in complementing conventional randomized controlled trials (RCTs) by capturing insights that accurately reflect clinical practice.
-
![Meeting, collaboration, working together, ideas-GettyImages-2193987470]( "Gain Instant Access To HEOR Education With On-Demand Programs")
The ISPOR Education Center provides instant access to Health Economics and Outcomes Research (HEOR) education with on-demand programs delivered through a personalized, powerful, and flexible learning platform. Working at their own time and pace, individuals can drive their professional development by growing their knowledge and skills with topical, relevant, and innovative course curricula.
-
![HOER-GettyImages-1309783183]( "HEOR Competencies: A Resource For HEOR Professionals")
Clear competency domains strengthen technical, communication, and strategic skills supporting adaptation to evidence trends, digital innovation, and patient‑centered research. See the full framework.
-
![powerful-partnerships-GettyImages-872019514]( "Creating Powerful Partnerships")
Deepen your impact in global healthcare through thought leadership, education, conferences, and partnerships that elevate visibility, strengthen expertise, and connect you with key HEOR stakeholders.
ISPOR VIDEOS
-
![Top HEOR Trends]( "ISPOR Top 10 HEOR Trends: What Are The Key Themes For 2026-27?")
Healthcare decision-making is evolving fast. Discover how AI, RWE, and changing HTA frameworks are influencing pricing, patient engagement, and market access.
-
![S1]( "Where RWE Is Still More Hype Than Reality")
There is a gap between promise and reality in using RWE for patient recruitment. And although some site-level success exists, Aaron Kamauu notes broader trial acceleration remains elusive, largely due to human factors like patient engagement and site execution.
-
![S2]( "Is Real-World Data Really \"Messy?\"")
Aaron Kamauu challenges the idea that real-world data is simply flawed, arguing it often reflects the inherent messiness of healthcare itself. He emphasizes understanding data origin, context, and alignment with trial populations as critical for meaningful interpretation.
-
![S3]( "Turning Messy Data Into Usable Evidence")
Kathleen Mandziuk explains how transforming “messy” real-world data starts with clearly defining the research question, identifying available datasets, and addressing gaps. She highlights linking datasets, statistical methods, and balancing sample size with data limitations to generate meaningful evidence.
-
![S4]( "Where RWE Actually Improves Trials")
Practical examples of RWE, according to Kathleen Mandziuk, include improving trial design, by refining I/E criteria, reducing patient burden, and using real-world behavior data. She highlights how mismatches between protocol demands and real patient lives can hurt recruitment and retention.
-
![Dive Into Core Topic Areas Of The HEOR field]( "Dive Into Core Topic Areas Of The HEOR field")
Join us to see how HEOR drives impact across the global healthcare landscape.
-
![Challenges And The Role Of HEOR]( "Patient Centered Research: Challenges And The Role Of HEOR")
How can research better reflect patient needs? Explore expert perspectives on Patient-Centered Research and the growing role of HEOR in decision-making.
-
![Leveraging AI In HEOR Innovation In Evidence And Outcomes]( "Leveraging AI In HEOR: Innovation In Evidence And Outcomes")
Stay at the forefront of digital innovation in healthcare and understand how artificial intelligence is revolutionizing Health Economics and Outcomes Research (HEOR) in this insightful video.
-
![Whole Health In Action Real-World Examples Of Better Outcomes]( "Whole Health In Action: Real-World Examples Of Better Outcomes")
Whole health looks beyond traditional care by addressing food access, environment, and lived experiences—leading to healthier communities and more holistic outcomes.
-
![Health Economics And Outcomes Research]( "Health Economics And Outcomes Research (HEOR) Explained")
Learn about this accessible way to understand what HEOR is, how it’s used, and its impact on people and healthcare systems.
-
![Drug Price Controls]( "Drug Price Controls: What Are The Unintended Consequences To Innovation?")
Review the ripple effects of drug price controls, including recent U.S. policy shifts like the IRA and President Trump’s Executive Order introducing International Reference Pricing.
CONTACT INFORMATION
ISPOR—The Professional Society for Health Economics and Outcomes Research
505 Lawrence Square Blvd South
Lawrenceville, NJ 08648
UNITED STATES
Phone: (609) 691-8942
Contact: Michelle Rovner
NEWS
-
Health Equity Research Goes Global—Without Waiting For Perfect Data3/4/2026
Value in Health Regional Issues published a special research collection showing meaningful progress in health equity across regions with varying data environments and policy needs.
-
International Study Confirms Universal Digital Health Framework3/4/2026
Value in Health published an international study showing the PICOTS‑ComTeC framework is an effective standard for defining patient-facing digital health interventions.
-
"Most-Favored Nation" Drug Pricing Strategy May Backfire, New Research Warns9/23/2025
Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a new analysis suggesting that the Trump Administration's "Most-Favored Nation" approach to lowering US drug prices by referencing international prices may not achieve its intended goals, based on decades of experience with similar policies in Europe. The report, “Referencing Drug Prices of Other Countries May Not Sustainably Lower Prices in the United States: Lessons From Europe” was published in the September 2025 issue of Value in Health.
-
ISPOR Real-World Evidence Summit 28-30 September 2025, Tokyo, Japan9/23/2025
ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced details for its ISPOR Real-World Evidence Summit 2025: Through The Lens of Asia Pacific.
-
ISPOR Champions Research Transparency With Launch Of Open Science Badges8/4/2025
ISPOR has introduced an initiative to recognize transparency in research for papers published in Value in Health, its preeminent HEOR journal.
-
November 9-12: ISPOR Europe 2025: Powering Value And Access Through Patient-Centered Collaboration7/15/2025
This year’s theme emphasizes the importance of strengthening partnerships across the healthcare ecosystem to accelerate patient-centered decision-making on healthcare value and access.
-
September 28-30: ISPOR Real-World Evidence Summit 2025: Through The Lens Of Asia Pacific7/15/2025
The Summit brings together top experts, decision makers, and industry leaders to explore the latest breakthroughs, share cutting-edge research, and discuss innovative solutions to the region’s most pressing healthcare challenges.
-
September 10-11: Communicating HEOR For Maximum Impact, Influence, And Understanding7/15/2025
Master the art of communicating HEOR evidence to diverse audiences. This course equips participants with tools to communicate their work clearly and effectively, ensuring its relevance and value are understood.
-
ISPOR Takes Health Research Mainstream With Plain Language Summaries6/30/2025
ISPOR launches its Plain Language Summaries program, an extension of their efforts to make health economics and outcomes research (HEOR) more accessible to patients, caregivers, and the general public.
FEATURED ARTICLES
-
![clinical-regulation-GettyImages-1423366794]( "US Healthcare System Overview")
A clear guide to U.S. coverage, regulation, and reimbursement: who decides care, how products gain access, and how policy and financing shape cost, value, and patient access.
-
![top-10-trends-GettyImages-2231462868]( "Top 10 HEOR Trends Report")
Emerging trends in HEOR reveal how AI, real‑world evidence, value‑based care, digital health, and evolving affordability pressures are reshaping global healthcare.
-
![trumprx_policy_GettyImages-2215852206]( "Policy To Practice: PBM Reform, TrumpRx, And Global Drug Development")
Policy shifts are reshaping PBM oversight, driving transparent drug‑pricing tools, and influencing global responses that affect affordability, access, and future pharma development.
-
![trends-clinical-GettyImages-1386103571]( "5 Trends To Watch This Year")
Explore 2026 policy trends across drug‑pricing actions, affordability pressures, value‑driven evaluation, shifts in global innovation, and new AI regulatory applications.
-
![Ispor CEO]( "Hope In The Dark: Value In Alzheimer's Disease Research And Treatment")
The May/June 2025 issue of Value & Outcomes Spotlight explores the health economics and outcomes research (HEOR) and its contribution to research and treatment of Alzheimer’s disease.
-
![rob-abbott]( "Enhancing The Accessibility And Affordability Of Healthcare")
The March/April 2025 issue of Value & Outcomes Spotlight explores the urgent global health crisis of accessibility and affordability, highlighting the nearly 2 billion individuals lacking essential medicines.
-
![GettyImages-1416816620 medical records, RWE]( "Top HEOR Trends")
Real-world evidence (RWE) offers insights into the effectiveness of medical treatments in everyday settings, with various stakeholders utilize RWE to enhance healthcare.
-
![GettyImages-944464752 research, teamwork, collaboration]( "ISPOR 2024-2025 Top 10 HEOR Trends")
This report outlines ten defining HEOR trends influencing global health decision-making.
-
![GettyImages-1293438556-document-computer-check-mark-magnifying-glass]( "HEOR In Action")
Health Economics and Outcomes Research (HEOR) plays a vital role in guiding evidence-based decisions across the healthcare ecosystem.
